siger han til TV 2. - Vi er en amerikansk virksomhed Novo Nordisk formåede i 2024 at hæve omsætningen med 25 procent, men kigger man på Nordamerika alene, voksede salget med 30 procent.

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t ...

With sales of Novo Nordisk ... ($6.2 billion) on similar projects. Meanwhile, thanks to the completion of Novo Holdings’ $16.5 billion Catalent acquisition in December, Novo Nordisk has ...

Morgan Stanley (NYSE:MS) initiated coverage on shares of Novo Nordisk (NOVOB:DC) (NYSE: NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic conditions. The ...

In a report released today, Jo Walton from UBS maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a price target of ...

Novo Nordisk A/S (NVO) on Wednesday reported fourth-quarter earnings of $4.04 billion. The Bagsvaerd, Denmark-based company said it had net income of 91 cents per share. The results exceeded Wall ...

Last September, Novo Nordisk reported Phase 2 obesity study results showing statistically significant weight loss at 16 weeks across all three doses tested. While gastrointestinal side effects ...

Sales of type 2 diabetes drug Ozempic jumped in 2024 by over a quarter to DKK120.3billion, as human insulin revenues increased by 15 per cent to DKK55.4billion. Consequently, Novo Nordisk's ...

On the charts, today's pop has NVO on track to snap a three-day losing streak. The stock still hasn't recovered from its ...

Danish drugmaker Novo Nordisk on Wednesday posted another quarter of rapid profit growth, though the story for once wasn’t its wildly popular weight-loss drugs. Novo Nordisk said its fourth ...